Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin. [electronic resource]
Producer: 20100405Description: 41-8 p. digitalISSN:- 1942-0870
- Adolescent
- Adult
- Aged
- Animals
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- adverse effects
- Carcinoma, Squamous Cell -- drug therapy
- Clinical Trials, Phase II as Topic
- Cuba
- ErbB Receptors -- antagonists & inhibitors
- Glioma -- drug therapy
- Head and Neck Neoplasms -- drug therapy
- Humans
- India
- Middle Aged
- Nasopharyngeal Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.